George L. Fotiades has been appointed interim president and chief executive officer of Catalent Pharma Solutions, effective immediately. John W. Lowry, the incumbent in this role, is leaving Catalent to pursue other opportunities. The search for Mr. Lowry’s replacement is ongoing. Mr. Fotiades has served as chairman since Catalent’s creation in 2007 and will continue to serve in that capacity. He brings strong experience to this role, having led the business from 2000 through 2004. Mr. ...